With over 20 years of experience in drug discovery, AI/machine learning, and multi-omic analysis, Dr. Ellis brings a deep reservoir of expertise to the field of biomedical research.

His distinguished career includes significant contributions to the development of blockbuster drugs along with a proven track record of grant funding, awards, and scientific publications.

Dr. Ellis most recently served at Netellis, where he led initiatives in neurodegenerative and endocrine diseases. His leadership has encompassed large-scale NGS projects, AI-driven platform development, and strategic partnerships. Previously, he has also managed virtual screening with numerous drug discovery modalities such as small molecule, monoclonal antibody, and peptide drug discovery. His technical acumen and visionary approach to AI and machine learning have consistently driven innovation and operational success across various research institutions and companies.